子痫前期循证医学证据汇总及比较：求同存异（第2部分）

龚娥; 王岚; 漆洪波

doi:10.19538/j.fk2025070121

PDF(896 KB)

中国实用妇科与产科杂志 ›› 2025, Vol. 41 ›› Issue (7) : 764-768. DOI: 10.19538/j.fk2025070121

综述与讲座

子痫前期循证医学证据汇总及比较：求同存异（第2部分）

龚娥 ¹ ,
王岚 ¹ ,
漆洪波 ²

作者信息 +

文章历史 +

导出引用

龚娥, 王岚, 漆洪波. 子痫前期循证医学证据汇总及比较：求同存异（第2部分）[J]. 中国实用妇科与产科杂志. 2025, 41(7): 764-768 https://doi.org/10.19538/j.fk2025070121

中图分类号： R714.24

参考文献

列表( 原文顺序 | 文献年度倒序 | 文中引用次数倒序 ) 可视化分析

[1]	Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia[J]. N Engl J Med, 2017, 377(7):613-622. DOI:10.1056/NEJMoa1704559. 本文引用 [1]

[2]	US Preventive Services Task Force. Aspirin use to prevent preeclampsia and related morbidity and mortality:US Preventive Services Task Force recommendation statement[J]. JAMA, 2021, 326:1186-1191. DOI:10.1001/jama.2021.14781. 本文引用 [1]

[3]	Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy:a meta-analysis[J]. Obstet Gynecol, 2010, 116:402-414. DOI:10.1097/AOG.0b013e3181e9322a. 本文引用 [1]

[4]	Roberge S, Nicolaides K, Demers S, et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction:systematic review and meta-analysis[J]. Am J Obstet Gynecol, 2017, 216:110-20.e6. DOI:10.1016/j.ajog.2016.09.076. 本文引用 [1]

[5]	Meher S, Duley L, Hunter K, et al. Antiplatelet therapy before or after 16 weeks’ gestation for preventing preeclampsia:an individual participant data meta-analysis[J]. Am J Obstet Gynecol, 2017, 216:121-8.e2. DOI:10.1016/j.ajog.2016.10.016. 本文引用 [1]

[6]	ACOG. ACOG Committee Opinion No. 743:low-dose aspirin use during pregnancy[J]. Obstet Gynecol, 2018, 132:e44-52. DOI:10.1097/AOG.0000000000002708. 本文引用 [1]

[7]	李伟, 丁娟, 马晓晴, 等. 子痫前期高危人群GPIba和COX-1基因多态性与阿司匹林抵抗的相关性研究[J]. 中国实用妇科与产科杂志, 2024, 40(1):119-123. DOI:10.19538/j.fk2024010124. 本文引用 [1]

[8]	Ayala DE, Ucieda R, Hermida RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy[J]. Chronobiol Int, 2013, 30(2):260-279. DOI:10.3109/07420528.2012.717455. 本文引用 [1]

[9]	Chappell LC, Cluver CA, Kingdom J, et al. Pre-eclampsia[J]. Lancet, 2021, 398(10297):341-354. DOI:10.1016/S0140-6736(15)00070-7. 本文引用 [1]

[10]	Davenport MH, Ruchat SM, Poitras VJ, et al. Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy:a systematic review and meta-analysis[J]. Br J Sports Med, 2018, 52(21):1367-1375. DOI:10.1136/bjsports-2018-099355. 本文引用 [1]

[11]	Woo Kinshella ML, Sarr C, Sandhu A, et al. Calcium for pre-eclampsia prevention:A systematic review and network meta-analysis to guide personalised antenatal care[J]. BJOG, 2022, 129(11):1833-1843. DOI:10.1111/1471-0528.17222. 本文引用 [1]

[12]	Alqudah A, McKinley MC, McNally R, et al. Risk of pre-eclampsia in women taking metformin:a systematic review and meta-analysis[J]. Diabet Med, 2018, 35(2):160-172. DOI:10.1111/dme.13523. 本文引用 [1]

[13]	Costantine MM, Cleary K, Hebert MF, et al. Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women:a pilot randomized controlled trial[J]. Am J Obstet Gynecol, 2016, 214(720):e1-17. DOI:10.1016/j.ajog.2015.12.038. 本文引用 [1]

[14]	Cruz-Lemini M, Vázquez JC, Ullmo J, et al. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications:a systematic review and meta-analysis[J]. Am J Obstet Gynecol, 2022, 226(2S):S1126-S1144.e17. DOI:10.1016/j.ajog.2020.11.006. 本文引用 [1]

[15]	Mottola MF, Davenport MH, Ruchat SM, et al. 2019 Canadian guideline for physical activity throughout pregnancy[J]. Br J Sports Med,2018, 52(21):1339-1346. DOI:10.1136/bjsports-2018-100056. 本文引用 [1]

[16]	Vidler M, Magee LA, Von Dadelszen P, et al. Women's views and postpartum follow-up in the CHIPS Trial(Control of Hypertension in Pregnancy Study)[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 206:105-113. DOI:10.1016/j.ejogrb.2016.07.509. 本文引用 [1]

[17]	Sridharan K, Sequeira RP. Drugs for treating severe hypertension in pregnancy:a network Meta-analysis and trial sequential analysis of randomized clinical trials[J]. Br J Clin Pharmacol, 2018, 84(9):1906-1916. DOI:10.1111/bcp.13649. 本文引用 [1]

[18]	杨孜. 推进子痫前期早发晚发病因分类临床分层共研究以循寻证有源致远[J]. 中国实用妇科与产科杂志, 2025, 41(1):15-22. DOI:10.19538/j.fk2025010105. 本文引用 [1]

[19]	Magee LA, Khalil A, Kametas N, et al. Toward personalized management of chronic hypertension in pregnancy[J]. Am J Obstet Gynecol, 2022, 226(2):S1196-S1210. DOI:10.1016/j.ajog.2020.07.026. 本文引用 [1]

[20]	Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy[J]. N Engl J Med, 2015, 372:407-17. DOI:10.1056/NEJMoa1404595. 本文引用 [1]

[21]	Pels A, Mol BWJ, Singer J, et al. Influence of gestational age at initiation of antihypertensive therapy:secondary analysis of CHIPS trial data (control of hypertension in pregnancy study)[J]. Hypertension, 2018, 71:1170-1177. DOI:10.1161/HYPERTENSIONAHA.117.10689. 本文引用 [1]

[22]	Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy[J]. Cochrane Database Syst Rev, 2013, 2013(7): CD001449. DOI:10.1002/14651858.CD001449.pub3. 本文引用 [1]

[23]	WHO. WHO recommendations:Policy of interventionist versus expectant management of severe pre-eclampsia before term[M]. Geneva: World Health Organization, 2018. 本文引用 [2]

[24]	Magee LA, Cham C, Waterman EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy:meta-analysis[J]. BMJ, 2003, 327:955-960. DOI:10.1136/bmj.327.7421.955. 本文引用 [1]

[25]

Koopmans

, Bijlenga

, Groen

, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation(HYPITAT):a multicentre,open-label randomised controlled trial[J]. Lancet, 2009, 374(9694):979-988. DOI:10.1016/S0140-6736(9)60736-4.

本文引用 [1]

[26]	张燕萍, 周容. 子痫前期重症预测和防范[J]. 中国实用妇科与产科杂志, 2024, 40(8):775-779. DOI:10.19538/j.fk2024080102. 本文引用 [1]

[27]	Magee LA, Pels A, Helewa M, et al. Diagnosis,evaluation,and management of the hypertensive disorders of pregnancy. Pregnancy Hypertension:An International Journal of Women’s Cardiovascular Health. 2014, 4:105-145. DOI:10.1016/j.preghy.2014.01.003. 本文引用 [1]

[28]	生殖健康及重大出生缺陷防控研究高龄产妇妊娠期并发症防治策略研究项目组. 子痫前期防治的集束化管理建议[J]. 中国实用妇科与产科杂志, 2022, 38(5):534-537.DOI:10.19538/j.fk2022050113. 本文引用 [1]

[29]	Duley L, Gülmezoglu AM, Chou D. Magnesium sulphate versus lytic cocktail for eclampsia[J]. Cochrane Database Syst Rev, 2010,(9): CD002960. DOI:10.1002/14651858.CD002960.pub2. 本文引用 [1]

[30]	Duley L, Henderson-Smart DJ, Chou D. Magnesium sulphate versus phenytoin for eclampsia[J]. Cochrane Database Syst Rev, 2010, 6(10):CD000128. DOI:10.1002/14651858.CD000128.pub2. 本文引用 [1]

[31]	Duley L, Gülmezoglu AM, Henderson-Smart DJ, et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia[J]. Cochrane Database Syst Rev, 2010,(11): CD000025. DOI:10.1002/14651858.CD000025.pub2. 本文引用 [1]

[32]	Duley L, Henderson-Smart DJ, Walker GJ, et al. Magnesium sulphate versus diazepam for eclampsia[J]. Cochrane Database Syst Rev, 2010,(12): CD000127. DOI:10.1002/14651858.CD000127.pub2. 本文引用 [1]

[33]	Grandi SM, Filion KB, Yoon S, et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications[J]. Circulation, 2019, 139:1069-1079. DOI:10.1161/CIRCULATIONAHA.118.036748. 本文引用 [1]

[34]	Smith GN, Louis JM, Saade GR. Pregnancy and the postpartum period as an opportunity for cardiovascular risk identification and management[J]. Obstet Gynecol, 2019, 134:851-862. DOI:10.1097/AOG.0000000000003363. 本文引用 [1]

[35]

Parikh

, Gonzalez

, Anderson

CAM

, et al. Adverse pregnancy outcomes and cardiovascular disease risk:unique opportunities for cardiovascular disease prevention in women:a scientific statement from the American Heart Association[J]. Circulation, 2021, 143:e902-916. DOI:10.1161/CIR.0000000000000961.

本文引用 [1]

[36]	Okoth K, Chandan JS, Marshall T, et al. Association between the reproductive health of young women and cardiovascular disease in later life:umbrella review[J]. BMJ, 2020,371:m3502. DOI:10.1136/bmj.m3502. 本文引用 [1]

[37]	梁宇, 李雪兰, 董欣, 等. 早发和晚发重度子痫前期心脏功能差异的探讨[J]. 中国实用妇科与产科杂志, 2024, 40(2):215-219.DOI:10.19538/j.fk2024020117. 本文引用 [1]

[38]	Magee LA, von Dadelszen P, Stones W, et al. The FIGO textbook of pregnancy hypertension:an evidence-based guide to monitoring,prevention and management[M]. London,England: Global Library of Women’s Medicine, 2016. 本文引用 [1]

[39]	ACOG. Barriers to breastfeeding:supporting initiation and continuation of breastfeeding:ACOG Committee Opinion,Number 821[J]. Obstet Gynecol, 2021, 137:e54-62. DOI:10.1097/AOG.0000000000004249. 本文引用 [1]

[40]

Mancia

, Kreutz

, Brunström

, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension:Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)[J]. J Hypertens, 2023, 41(12):1874-2071. DOI:10.1097/HJH.0000000000003480.

本文引用 [1]

[41]	Wicin´ski M, Malinowski B, Puk O, et al. Methyldopa as an inductor of postpartum depression and maternal blues:a review[J]. Biomed Pharmacother, 2020, 127:110196. DOI:10.1016/j.biopha.2020.110196. 本文引用 [1]